Coffee and myocardial infarction: Heterogeneity of an association in Portuguese men

European Journal of Preventive Cardiology

Volumn 13, Issue 2, 2006, Pages 268-273

  Azevedo, Ana ^a   Barros, Henrique ^a  

^a University of Porto   (Portugal)

Author keywords

acute myocardial infarction; caffeine; case control studies; coffee; coronary artery disease; effect measure modification; family history; interaction; population based study

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COFFEE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIET; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRINKING BEHAVIOR; FAMILY HISTORY; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZATION;

ADULT; BODY SIZE; CAFFEINE; COFFEE; ENERGY INTAKE; HUMANS; MALE; MYOCARDIAL INFARCTION; PORTUGAL; QUESTIONNAIRES; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 33746189862     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000214604.53372.2b     Document Type: Article

References (36)

1. James JE, editor. Caffeine and cardiovascularhealth. In: Understanding caffeine - a biobehavioralanalysis. Thousand Oaks: Sage Publications; 1997, pp.80–102.
2. Jee SH, Jiang H, Whelton PK, Suh I, Klag MJ. The effect of chronic coffee drinking on bloodpressure. A meta-analysis of controlled clinical trials. Hypertension 1999; 3: 647–652.
3. Hartley TR, Lovallo WR, Whitsett TL. Cardiovascular effects of caffeine in men andwomen. Am J Cardiol 2004; 93: 1022–1026.
4. Mahmud A, Feely J. Acute effect of caffeine on arterial stiffnessand aortic pressure waveform. Hypertension 2001; 38: 227–231.
5. Serafin WE. Drugs used in the treatment ofasthma. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman's Thepharmacological basis of therapeutics. NewYork: McGraw-Hill; 1996; pp. 659.
6. Urgert R, van der Weg G, Kosmeijer-Schuil TG, van de Bovenkamp P, Hovenier R, Katan MB. Levels of the cholesterol-elevating diterpenescafestol and kahweol in various coffee brews. JAgric Food Chem 1995; 43: 2167–2172.
7. Strandhagen E, Thelle DS. Filtered coffee raises serum cholesterol:results from a controlled study. Eur J Clin Nutr 2003; 57: 1164–1168.
8. Jee SH, Jiang H, Appel LJ, Whelton PK, Suh I, Klag MJ. Coffee consumption and serum lipids: ameta-analysis of randomized controlled clinical trials. Am J Epidemiol 2001; 153: 353–362.
9. Miyake Y, Kono S, Nishiwaki M, Hamada H, Nishikawa H, Koga H, Ogawa S. Relationship of coffee consumption with serumlipids and lipoproteins in Japanese men. AnnEpidemiol 1999; 9: 121–126.
10. Massey LK, Wise KJ. The effect of dietary caffeine on urinaryexcretion of calcium, magnesium, phosphorus, sodium, potassium, chloride andzinc in healthy males. Nutr Res 1985; 5: 1281–1284.
11. Grubben MJ, Boers GH, Blom HJ, Broekhuizen R, De Jong R, van Rijt L, et al. Unfiltered coffee increases plasma homocysteineconcentrations in healthy volunteers: a randomized trial. Am J Clin Nutr 2000; 71: 480–484.
12. El-Khainy L, Ueland PM, Nygard O, Refsun H, Vollset SE. Lifestyle and cardiovascular disease riskfactors as determinants of total cysteine in plasma: the HordalandHomocysteine Study. Am J Clin Nutr 1999; 70: 1016–1024.
13. Mennen LI, De Courcy GP, Guilland JC, Ducros V, Bertrais S, Nicolas JP, et al. Homocysteine, cardiovascular disease riskfactors, and habitual diet in the French Supplementation with AntioxidantVitamins and Minerals Study. Am J Clin Nutr 2002; 76: 1279–1289.
14. Greenland S. A meta-analysis of coffee, myocardialinfarction, and coronary death. Epidemiology 1993; 4: 366–374.
15. Willet W. Coffee and coronary heart disease. A new problemwith old brew? [Editorial]. Ann Epidemiol 1994; 4: 497–498.
16. Tavani A, Bertuzzi M, Gallus S, Negri E, La Vecchia C. Risk factors for non-fatal acute myocardialinfarction in Italian women. Prev Med 2004; 39: 128–134.
17. Sesso HD, Gaziano JM, Buring JE, Hennekens CH. Coffee and tea intake and the risk of myocardialinfarction. Am J Epidemiol 1999; 149: 162–167.
18. Kleemola P, Jousilahti P, Pietinen P, Vartiainen E, Tuomilehto J. Coffee consumption and the risk of coronaryheart disease and death. Arch Intern Med 2000; 160: 3393–3400.
19. Tavani A, Bertuzzi M, Negri E, Sorbara L, La Vecchia C. Alcohol, smoking, coffee and risk of non-fatalacute myocardial infarction in Italy. Eur JEpidemiol 2001; 17: 1131–1137.
20. Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related tothe risk of acute coronary events in middle-aged men. J Nutr 2004; 134: 2381–2386.
21. Puccio EM, McPhillips JB, Barrett-Connor E, Ganiats TG. Clustering of atherogenic behaviors in coffeedrinkers. Am J Public Health 1990; 80: 1310–1313.
22. Leviton A. Coffee consumption and residual confounding[Letter]. Epidemiology 1996; 7: 110–111.
23. Porta M, Vioque J, Ayude D, Alguacil J, Jariod M, Ruiz L, Murillol JA. Coffee drinking: the rationale for treating itas a potential effect modifier of carcinogenic exposures. Eur J Epidemiol 2003; 18: 289–298.
24. Folstein MF, Folstein SE, McHush PR. “Mini-mental state”. Apractical method for grading the cognitive state of patients for theclinician. J Psych Res 1975; 12: 189–198.
25. Azevedo A, Ramos E, von Hafe P, Barros H. Upper-body adiposity and risk of myocardialinfarction. J Cardiovasc Risk 1999; 6: 321–325.
26. Kawachi I, Colditz GA, Stone CB. Does coffee drinking increase the risk ofcoronary heart disease? Results from a meta-analysis. Br Heart J 1994; 72: 269–275.
27. Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C. The J-shaped effect of coffee consumption on therisk of developing acute coronary syndromes: the CARDIO2000case–control study. J Nutr 2003; 133: 3228–3232.
28. D'Amicis A, Scaccini C, Tomassi G, Anaclerio M, Stornelli R, Bernini A. Italian style brewed coffee: effect on serumcholesterol in young men. Int J Epidemiol 1996; 25: 513–520.
29. Ramos E, Lopes C, Barros H. Investigating the effect of nonparticipationusing a population-based case-control study on myocardialinfarction. Ann Epidemiol 2004; 14: 437–441.
30. Tzonou A, Kalandidi A, Trichopoulou A, Hsiech CC, Toupadaki N, Willett W, Trichopoulos D. Diet and coronary heart disease: a case-controlstudy in Athens, Greece. Epidemiology 1993; 4: 511–516.
31. Slack J, Evans KA. The increased risk of death from ischaemic heartdisease in first degree relatives of 121 men and 96 women with ischaemicheart disease. J Med Genet 1966; 3: 239–257.
32. Palmer J.R., Rosenberg L, Sowmya Rao R, Shapiro S. Coffee consumption and myocardial infarction inwomen. Am J Epidemiol 1995; 141: 724–731.
33. Peyser PA. Genetic epidemiology of coronary arterydisease. Epidemiol Rev 1997; 19: 80–90.
34. Clarkson P, Celermajer DS, Powe AJ, Donald AE, Henry RM, Deanfield JE. Endothelium-dependent dilatation is impaired inyoung healthy subjects with a family history of premature coronarydisease. Circulation 1997; 96: 3378–3383.
35. Kawachi I, Willett WC, Colditz GA, Stampfer MJ, Speizer FE. A prospective study of coffee drinking andsuicide in women. Arch Intern Med 1996; 156: 521–525.
36. Stamler J, Caggiula AW, Grandits GA. Relation of body mass and alcohol, nutrient,fiber, and caffeine intakes to blood pressure in the special interventionand usual care groups in the Multiple Risk Factor InterventionTrial. Am J Clin Nutr 1997; 65(Suppl.):338S–365S.